Hershey Trust CO Adverum Biotechnologies, Inc. Transaction History

Hershey Trust CO

  • $396 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$2.08 - $3.6 $7,716 - $13,356
-3,710 Closed
0 $0
Q1 2021

Apr 29, 2021
SELL
$9.26 - $14.36 $241,704 - $374,824
-26,102 Reduced 87.56%
3,710 $37,000
Q4 2020

Jan 21, 2021
BUY
$9.84 - $14.26 $293,350 - $425,119
29,812 New
29,812 $323,000

Others Institutions Holding ADVM

# of Institutions
3
Shares Held
524K
Call Options Held
0
Put Options Held
0
View Full List

About Adverum Biotechnologies, Inc.

ADVM Quotes by TradingView
  • Ticker ADVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,333,600
  • Market Cap $471M
  • Description
  • Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...
More about ADVM
Track This Portfolio

Track Hershey Trust CO Portfolio

Follow Hershey Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hershey Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Hershey Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email